Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Goldee Pardesi, Associate Vice President - Sales & Marketing at Alembic Pharmaceuticals, has tendered his resignation effective 3rd February 2026. In his resignation email, Pardesi cited pursuit of new opportunities aligned with his professional and personal goals as the reason for leaving. He committed to ensuring a smooth transition and minimal disruption to the business operations. The company filed this intimation on 4th May 2026, confirming the cessation date as 5th May 2026.
The departure of the AVP Sales & Marketing is a mid-level management change. While it is unlikely to have a significant immediate impact on stock price, it may cause temporary disruption in the sales and marketing function pending a suitable replacement.